ERAS

ERAS

USD

Erasca Inc. Common Stock

$1.520-0.060 (-3.797%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.580

最高价

$1.615

最低价

$1.515

成交量

1.46M

公司基本面

市值

430.6M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

1.73M

交易所

NMS

货币

USD

52周价格范围

最低价 $1.01当前价 $1.520最高价 $3.45

相关新闻

Analyst Upgrades

Raymond James Initiates Coverage On Erasca with Outperform Rating, Announces Price Target of $5

Raymond James analyst Laura Prendergast initiates coverage on Erasca with a Outperform rating and announces Price Target of $5.

查看更多
Raymond James Initiates Coverage On Erasca with Outperform Rating, Announces Price Target of $5
GlobeNewswire

Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting

Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP complex inhibitors,

查看更多
Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting
Analyst Upgrades

Goldman Sachs Maintains Buy on Erasca, Lowers Price Target to $3

Goldman Sachs analyst Chris Shibutani maintains Erasca with a Buy and lowers the price target from $3.5 to $3.

查看更多
Goldman Sachs Maintains Buy on Erasca, Lowers Price Target to $3
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target

HC Wainwright & Co. analyst Andres Maldonado reiterates Erasca with a Buy and maintains $6 price target.

查看更多
HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target
Analyst Upgrades

Morgan Stanley Assumes Erasca at Overweight, Maintains Price Target of $4

Morgan Stanley analyst Jeffrey Hung assumes Erasca with a Overweight rating and maintains Price Target of $4.

查看更多
Morgan Stanley Assumes Erasca at Overweight, Maintains Price Target of $4